Why Arbutus Biopharma Is Rocketing Higher Today

Why Arbutus Biopharma Is Rocketing Higher Today
·1 min read

What happened Shares of Arbutus Biopharma (NASDAQ: ABUS) rocketed higher on Wednesday morning in response to a court ruling in its favor. The stock was up 70.2% at 11:41 a.m. on Wednesday. So what Moderna's (NASDAQ: MRNA) attempt to avoid paying royalties on the lipid nanoparticle (LNP) technology that its COVID vaccine relies upon took another turn for the worse.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting